84.08 +1.60 (1.94%)
After hours: 4:18PM EST
|Bid||77.00 x 800|
|Ask||95.00 x 800|
|Day's Range||81.65 - 84.78|
|52 Week Range||77.28 - 106.27|
|Beta (3Y Monthly)||1.30|
|PE Ratio (TTM)||10.95|
|Earnings Date||Feb 4, 2019 - Feb 8, 2019|
|Forward Dividend & Yield||1.60 (1.90%)|
|1y Target Est||92.79|
NEW YORK, Dec. 10, 2018 -- Levi & Korsinsky announces it has commenced an investigation of AmerisourceBergen Corporation (NYSE: ABC) concerning possible violations of.
Is AmerisourceBergen Corporation (NYSE:ABC) a good bet right now? We like to analyze hedge fund sentiment before doing days of in-depth research. We do so because hedge funds and other elite investors have numerous Ivy league graduates, expert network advisers, and supply chain tipsters working or consulting for them. There is not a shortage of […]
The solar installation is expected to offset more than 80 percent of the distribution center’s annual electricity consumption.
NEW YORK, Dec. 04, 2018 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors,.
Humana finished the day down 1 percent, after earlier falling as much as 3.5 percent. Walgreens closed down 2.6, after earlier losing as much as 4.4 percent. The companies have held discussions about a variety of joint ventures, the Journal reported, including expanding their partnership serving older people.
AmerisourceBergen Corp is a pharmaceutical services company. The dividend yield of AmerisourceBergen Corp stocks is 1.75%. AmerisourceBergen Corp had annual average EBITDA growth of 10.90% over the past ten years.
Opioid makers and distributors are fighting a novel New York state law that aims to collect hundreds of millions of dollars from the industry to help defray costs of the opioid crisis, with some companies re-engineering their supply chain to avoid the new tax. Companies and trade groups have argued in three legal challenges filed in recent months that the law, which seeks $600 million over six years, is unconstitutional. New York’s health department sent bills last week to 75 companies and their subsidiaries detailing how much they owe under the new Opioid Stewardship Act.
Investing.com – A rout in Apple and Facebook (NASDAQ:FB) Monday swept through tech, prompting a wave of selling across the broader market.
The Zacks Analyst Blog Highlights: Pfizer, Cisco, Southern, SunTrust Banks and AmerisourceBergen
AQR Capital Management is a $226 billion global investment management firm launched back in 1998, by a guru in the financial world, billionaire Cliff Asness. Among other accomplishments, he became well regarded in the investing universe, thanks to his doctoral dissertation for which he closely studied the use of technical analysis to determine undervalued stocks. During […]
Shares of AmerisourceBergen Corporation (NYSE:ABC) will begin trading ex-dividend in 4 days. To qualify for the dividend check of US$0.40 per share, investors must have owned the shares prior to Read More...
The goal of this article is to teach you how to use price to earnings ratios (P/E ratios). We’ll show how you can use AmerisourceBergen Corporation’s (NYSE:ABC) P/E ratio to Read More...
Shares of AmerisourceBergen Corp. tumbled 9.1% in morning trade Tuesday, after the drug company reported fiscal fourth-quarter earnings and revenue that just topped expectations but provided a downbeat profit outlook, citing a "potential sizable headwind" for its PharMEDium business. The company also disclosed in filing with the Securities and Exchange Commission that production at PharMEDium's facilities remains suspended, while Leerink analyst David Larsen said commercial operations were previously expected to begin in September, as the company waited for feedback from the Food and Drug Administration. Earlier Tuesday, the company reported fourth-quarter net income of $233.3 million, or $1.07 a share, compared with a loss of $344.6 million, or $1.58 a share, in the same period a year ago. Adjusted earnings per share came to $1.45, above the FactSet consensus of $1.44, but the fiscal 2019 adjusted EPS outlook of $6.65 to $6.95 was below expectations of $7.11. The stock has lost 2.0% over the past three months, while the SPDR Health Care Select Sector ETF has gained 0.3% and the S&P 500 has lost 3.6%.
AmerisourceBergen (ABC) registers strong growth in the Pharmaceutical Distribution segment and the World Courier business in Q4.
Steve Collis has been the CEO of AmerisourceBergen Corporation (NYSE:ABC) since 2011. First, this article will compare CEO compensation with compensation at other large companies. After that, we will consider Read More...
AmerisourceBergen (ABC) delivered earnings and revenue surprises of 0.69% and -0.53%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?